Literature DB >> 15354407

Reduced low-density-lipoprotein cholesterol causing low serum cholesterol levels in gastrointestinal cancer: a case control study.

Y Tomiki1, S Suda, M Tanaka, A Okuzawa, M Matsuda, Y Ishibiki, K Sakamoto, T Kamano, M Tsurumaru, Y Watanabe.   

Abstract

Several epidemiological studies suggested an inverse relation between serum cholesterol level and cancer mortality. We analyzed the relation between gastrointestinal cancers and serum cholesterol levels. A total of 631 patients were recruited as cancer-bearing cases, comprising 181 esophageal cancers, 251 gastric cancers and 199 colorectal cancers. A case-control analysis was conducted on the serum TC, HDL-C, LDL-C and TG levels. TC and LDL-C were significantly lower in cancer-bearers by approximately 15 mg/dl. Furthermore, analyses by cancer site also showed significantly lower TC and LDL-C levels in cancer-bearers than in controls for all three sites. In this analysis, early stage cancer-bearers showed a significant decrease in TC levels by approximately 11 mg/dl compared with controls, and also a similar decrease in LDL-C levels. These results suggest that low TC levels are not related to cancer stage. Furthermore, findings of no significant differences in HDL-C and TG between cancer-bearing cases and controls in addition to a specific decrease in LDL-C in cancer-bearers suggest that hypocholesterolemia observed in these cases stems from low LDL-C. However, cancer-bearers and controls showed a similar distribution of TC and LDL-C levels. We should be aware that latent cancer bearers may be present among subjects with hypocholesterolemia.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15354407

Source DB:  PubMed          Journal:  J Exp Clin Cancer Res        ISSN: 0392-9078


  18 in total

1.  MMP-9 polymorphisms are related to serum lipids levels but not associated with colorectal cancer susceptibility in Chinese population.

Authors:  Zhi-Hui Yang; Shi-Ning Li; Jin-Xing Liu; Qing-Xi Guo; Xing-Wang Sun
Journal:  Mol Biol Rep       Date:  2012-06-24       Impact factor: 2.316

2.  Lipid levels in serum and cancerous tissues of colorectal cancer patients.

Authors:  Xin Zhang; Xian-Wen Zhao; Dong-Bo Liu; Cun-Zhi Han; Li-Li Du; Jie-Xiang Jing; Yan Wang
Journal:  World J Gastroenterol       Date:  2014-07-14       Impact factor: 5.742

3.  Role of cholesterol in the development and progression of breast cancer.

Authors:  Gemma Llaverias; Christiane Danilo; Isabelle Mercier; Kristin Daumer; Franco Capozza; Terence M Williams; Federica Sotgia; Michael P Lisanti; Philippe G Frank
Journal:  Am J Pathol       Date:  2010-12-23       Impact factor: 4.307

4.  Prediction of lipid-binding sites based on support vector machine and position specific scoring matrix.

Authors:  Wenjia Xiong; Yanzhi Guo; Menglong Li
Journal:  Protein J       Date:  2010-08       Impact factor: 2.371

5.  The novel anticancer agent JNJ-26854165 induces cell death through inhibition of cholesterol transport and degradation of ABCA1.

Authors:  Richard J Jones; Dongmin Gu; Chad C Bjorklund; Isere Kuiatse; Alan T Remaley; Tarig Bashir; Veronique Vreys; Robert Z Orlowski
Journal:  J Pharmacol Exp Ther       Date:  2013-07-02       Impact factor: 4.030

6.  Controlling Nutritional Status Score Serves as a Prognosticator in Esophageal Squamous Cell Carcinoma: Optimal Timing of Evaluation of Patients Undergoing Neoadjuvant Treatment.

Authors:  Ikue Nonogaki; Mitsuro Kanda; Dai Shimizu; Yoshikuni Inokawa; Norifumi Hattori; Masamichi Hayashi; Chie Tanaka; Masahiko Koike; Goro Nakayama; Yasuhiro Kodera
Journal:  World J Surg       Date:  2022-10-05       Impact factor: 3.282

7.  Effect of dietary patterns differing in carbohydrate and fat content on blood lipid and glucose profiles based on weight-loss success of breast-cancer survivors.

Authors:  Henry J Thompson; Scot M Sedlacek; Devchand Paul; Pamela Wolfe; John N McGinley; Mary C Playdon; Elizabeth A Daeninck; Sara N Bartels; Mark R Wisthoff
Journal:  Breast Cancer Res       Date:  2012-01-06       Impact factor: 6.466

8.  Hypolipidemia: a word of caution.

Authors:  Rr Elmehdawi
Journal:  Libyan J Med       Date:  2008-06-01       Impact factor: 1.657

Review 9.  Influence of liver cancer on lipid and lipoprotein metabolism.

Authors:  Jingting Jiang; Peter Nilsson-Ehle; Ning Xu
Journal:  Lipids Health Dis       Date:  2006-03-03       Impact factor: 3.876

10.  The clinical significance of preoperative serum cholesterol and high-density lipoprotein-cholesterol levels in hepatocellular carcinoma.

Authors:  Shan-Shan Jiang; De-Sheng Weng; Long Jiang; Yao-Jun Zhang; Ke Pan; Qiu-Zhong Pan; Chang-Long Chen; Jing-Jing Zhao; Xiao-Fei Zhang; Hong-Xia Zhang; Yan Tang; Zi-Qi Zhou; Min-Shan Chen; Jian-Chuan Xia
Journal:  J Cancer       Date:  2016-03-20       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.